Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 438

1.

Ciproxifan, a histamine H3-receptor antagonist/inverse agonist, potentiates neurochemical and behavioral effects of haloperidol in the rat.

Pillot C, Ortiz J, Héron A, Ridray S, Schwartz JC, Arrang JM.

J Neurosci. 2002 Aug 15;22(16):7272-80.

2.
3.

Histamine H3 and dopamine D2 receptor-mediated [35S]GTPgamma[S] binding in rat striatum: evidence for additive effects but lack of interactions.

Humbert-Claude M, Morisset S, Gbahou F, Arrang JM.

Biochem Pharmacol. 2007 Apr 15;73(8):1172-81. Epub 2007 Jan 7.

PMID:
17306767
4.

Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist.

Ligneau X, Lin J, Vanni-Mercier G, Jouvet M, Muir JL, Ganellin CR, Stark H, Elz S, Schunack W, Schwartz J.

J Pharmacol Exp Ther. 1998 Nov;287(2):658-66.

5.
6.

N-methyl-D-aspartate receptor antagonists enhance histamine neuron activity in rodent brain.

Faucard R, Armand V, Héron A, Cochois V, Schwartz JC, Arrang JM.

J Neurochem. 2006 Sep;98(5):1487-96.

7.

A detailed mapping of the histamine H(3) receptor and its gene transcripts in rat brain.

Pillot C, Heron A, Cochois V, Tardivel-Lacombe J, Ligneau X, Schwartz JC, Arrang JM.

Neuroscience. 2002;114(1):173-93.

PMID:
12207964
8.

Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs.

Zhang M, Ballard ME, Pan L, Roberts S, Faghih R, Cowart M, Esbenshade TA, Fox GB, Decker MW, Hancock AA, Rueter LE.

Brain Res. 2005 May 31;1045(1-2):142-9. Epub 2005 Apr 20.

PMID:
15910772
9.
12.

Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.

Obuchowicz E, Krysiak R, Wieronska JM, Smialowska M, Herman ZS.

Neuropeptides. 2005 Oct;39(5):515-23. Epub 2005 Sep 9.

PMID:
16154634
13.
14.

Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions.

Ridray S, Griffon N, Mignon V, Souil E, Carboni S, Diaz J, Schwartz JC, Sokoloff P.

Eur J Neurosci. 1998 May;10(5):1676-86.

PMID:
9751140
15.

Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040.

Southam E, Cilia J, Gartlon JE, Woolley ML, Lacroix LP, Jennings CA, Cluderay JE, Reavill C, Rourke C, Wilson DM, Dawson LA, Medhurst AD, Jones DN.

Psychopharmacology (Berl). 2009 Jan;201(4):483-94. doi: 10.1007/s00213-008-1310-9. Epub 2008 Sep 3.

PMID:
18762914
17.

The effects of haloperidol on dopamine receptor gene expression.

Fox CA, Mansour A, Watson SJ Jr.

Exp Neurol. 1994 Dec;130(2):288-303.

18.

The histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDA-induced excitotoxicity through the cAMP/protein kinase A pathway in cultured cortical neurons.

Dai H, Fu Q, Shen Y, Hu W, Zhang Z, Timmerman H, Leurs R, Chen Z.

Eur J Pharmacol. 2007 Jun 1;563(1-3):117-23. Epub 2007 Feb 8.

PMID:
17350613
20.

Supplemental Content

Support Center